Patents by Inventor Kenneth S. Rosenthal

Kenneth S. Rosenthal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for Modulating Immunogenic Responses by Activating Dendritic Cells
    Publication number: 20120039926
    Abstract: The conjugated peptide constructs described herein can be used to induce production of dendritic cells that generate cytokines. The vaccine-bearing dendritic cells can be administered to induce T cell mediated immune modulating responses.
    Type: Application
    Filed: April 14, 2010
    Publication date: February 16, 2012
    Applicants: CEL-SCI CORPORATION, NORTHEASTERN OHIO UNIVERSITIES COLLEGE OF MEDICINE
    Inventors: Kenneth S. Rosenthal, Daniel H. Zimmerman, Patricia R. Taylor
  • Immunogenic conjugated polypeptide for treatment of herpes simplex virus
    Patent number: 6572860
    Abstract: Peptide constructs chemically synthesized to contain a Herpes Simplex Virus specific antigenic peptide, such as, the 322-332 peptide (H1) from the ICP27 protein of Herpes Simplex Virus (HSV-1) and a peptide from a T cell binding ligand (TCBL), such as &bgr;-2M (aa 35-50), which elicits a TH1-like response in vitro tests in mice, were protective against challenge with HSV.
    Type: Grant
    Filed: March 30, 2000
    Date of Patent: June 3, 2003
    Assignee: CEL-SCI Corporation
    Inventors: Daniel H. Zimmerman, Kenneth S. Rosenthal